Abstract:Background: The present study aims to evaluate the cost-effectiveness of the newly introduced varicella and herpes zoster (HZ) vaccination programmes in Italy. The appropriateness of the introduction of the varicella vaccine is highly debated because of concerns about the consequences on HZ epidemiology and the expected increase in the number of severe cases in case of suboptimal coverage levels. Methods: We performed a cost-utility analysis based on a stochastic individual-based model that considers realistic demographic processes and two different underlying mechanisms of exogenous boosting (temporary and progressive immunity). Routine varicella vaccination is given with a two-dose schedule (15 months, 5-6 years). The HZ vaccine is offered to the elderly (65 years), either alone or in combination with an initial catch-up campaign (66-75 years). The main outcome measures are averted cases and deaths, costs per quality-adjusted life years gained, incremental cost-effectiveness ratios, and net monetary benefits associated with the different vaccination policies. Results: Demographic processes have contributed to shaping varicella and HZ epidemiology over the years, decreasing varicella circulation and increasing the incidence of HZ. The recent introduction of varicella vaccination in Italy is expected to produce an enduring reduction in varicella incidence and, indirectly, a further increase of HZ incidence in the first decades, followed by a significant reduction in the long term. However, the concurrent introduction of routine HZ vaccination at 65 years of age is expected to mitigate this increase and, in the longer run, to reduce HZ burden to its minimum. From an economic perspective, all the considered policies are cost-effective, with the exception of varicella vaccination alone when considering a time horizon of 50 years. These results are robust to parameter uncertainties, to the two different hypotheses on the mechanism driving exogenous boosting, and to different demographic projection scenarios. Conclusions: The recent introduction of a combined varicella and HZ vaccination programme in Italy will produce significant reductions in the burden of both diseases and is found to be a cost-effective policy. This programme will counterbalance the increasing trend of zoster incidence purely due to demographic processes.

Varicella susceptibility and transmission dynamics in Slovenia

Varicella zoster virus transmission dynamics in Vojvodina, Serbia

The social contact hypothesis under the assumption of endemic equilibrium: Elucidating the transmission potential of VZV in Europe

The Long-Term Clinical and Economic Impact of Universal Varicella Vaccination in Slovenia

Ambispective epidemiological observational study of varicella-zoster virus infection: An 18 year-single-center Bulgarian experience

[Sero-epidemiology of VZV infection in Italy: impact evaluation of extensive vaccination]

Seroprevalence of varicella-zoster virus as measured by fluorescent antibody to membrane antigen assay and glycoprotein enzyme-linked immunosorbent assay more than 10 years after initiation of a universal vaccination program: An observational study

A population database analysis to estimate the varicella vaccine effectiveness in children < 14 years in a high vaccination coverage area from 2004 to 2022

Long -term persistence of antibodies against varicella in fully immunized healthcare workers: an Italian retrospective cohort study

The seroepidemiology and transmission dynamics of varicella in Australia

Reconstructing the transmission dynamics of varicella in Japan: an elevation of age at infection

Epidemiology and cost analysis of varicella in Italy: results of a sentinel study in the pediatric practice. Italian Sentinel Group on Pediatric Infectious Diseases

Human papillomavirus-specific antibody status among unvaccinated subjects in the region of Vojvodina, Serbia

Probability of exposure to the wild measles virus in adult population – Estimation from seroepidemiology and historical data

Seroprevalence and Molecular Characteristics of Varicella-Zoster Virus Infection in Chinese Children.

Correlation of Herd Immunity to Measles Vaccination Rate and Disease Incidence

Modeling the transmission dynamics of varicella in Hungary

Raising Epidemiological Awareness: Assessment of Measles/MMR Susceptibility in Highly Vaccinated Clusters within the Hungarian and Croatian Population—A Sero-Surveillance Analysis

Seroepidemiology of Human Parvovirus B19 Infection among the Population of Vojvodina, Serbia, over a 16-Year Period (2008–2023)

Seasonality and Genotype Diversity of Human Rhinoviruses during an Eight-Year Period in Slovenia

The impact of demographic changes, exogenous boosting and new vaccination policies on varicella and herpes zoster in Italy: a modelling and cost-effectiveness study